|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001721,
umls-concept:C0007634,
umls-concept:C0017262,
umls-concept:C0017349,
umls-concept:C0030705,
umls-concept:C0038952,
umls-concept:C0042210,
umls-concept:C0185117,
umls-concept:C0205263,
umls-concept:C0301872,
umls-concept:C0439859,
umls-concept:C0796561,
umls-concept:C2911684
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
2009-7-31
|
|
pubmed:abstractText |
Autologous melanoma cells display a broad variety of tumor antigens and were used for treatment of American Joint Committee on Cancer stages III and IV melanoma as an adjuvant or active therapy. Survival data and immune response were evaluated in vaccinated patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2,4-Dinitrophenol,
http://linkedlifedata.com/resource/pubmed/chemical/Adaptor Proteins, Signal Transducing,
http://linkedlifedata.com/resource/pubmed/chemical/BIRC7 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cancer Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class II,
http://linkedlifedata.com/resource/pubmed/chemical/Inhibitor of Apoptosis Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/SILV protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/gp100 Melanoma Antigen
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:DavidInna BenIB,
pubmed-author:EliasOritO,
pubmed-author:FrankenburgShoshanaS,
pubmed-author:GimmonZviZ,
pubmed-author:HamburgerTamarT,
pubmed-author:KadouriLunaL,
pubmed-author:KuznetzAnnaA,
pubmed-author:LotemMichalM,
pubmed-author:MachlenkinArthurA,
pubmed-author:NissanAviramA,
pubmed-author:PeretzTamarT,
pubmed-author:ShiloniEitanE
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4968-77
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19602547-2,4-Dinitrophenol,
pubmed-meshheading:19602547-Adaptor Proteins, Signal Transducing,
pubmed-meshheading:19602547-Autoimmunity,
pubmed-meshheading:19602547-CD4-Positive T-Lymphocytes,
pubmed-meshheading:19602547-CD8-Positive T-Lymphocytes,
pubmed-meshheading:19602547-Cancer Vaccines,
pubmed-meshheading:19602547-Cell Line, Tumor,
pubmed-meshheading:19602547-Histocompatibility Antigens Class II,
pubmed-meshheading:19602547-Humans,
pubmed-meshheading:19602547-Immunity, Cellular,
pubmed-meshheading:19602547-Immunity, Humoral,
pubmed-meshheading:19602547-Immunotherapy,
pubmed-meshheading:19602547-Inhibitor of Apoptosis Proteins,
pubmed-meshheading:19602547-Interferon-gamma,
pubmed-meshheading:19602547-Kaplan-Meier Estimate,
pubmed-meshheading:19602547-Melanoma,
pubmed-meshheading:19602547-Membrane Glycoproteins,
pubmed-meshheading:19602547-Neoplasm Proteins,
pubmed-meshheading:19602547-Skin Neoplasms,
pubmed-meshheading:19602547-gp100 Melanoma Antigen
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Autologous melanoma vaccine induces antitumor and self-reactive immune responses that affect patient survival and depend on MHC class II expression on vaccine cells.
|
|
pubmed:affiliation |
Sharett Institute of Oncology and Departments of Surgery, Hadassah Hebrew University Hospital, Ein Karem and Mount Scopus Campuses, Jerusalem, Israel. mlotem@hadassah.org.il
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
